HMD-301 for diagnosis of Urinary Tract Infection: novel clinical results published
Urinary tract infection (UTI) is a common infection diagnosis in children, and efficient diagnosis and treatment is important to avoid serious complications. The published study shows that by quantifying the level of Heparin Binding Protein in urine samples, individuals with UTI could be discerned with sensitivity above 90 % and specificity above 90%. These levels of accuracy are highly competitive in comparison with the commonly used methods for UTI-diagnosis today: Nitrite quantification, White Blood Cell count or Interleukin-6 quantification. The study involved a small group of patients (78 children aged 0-18 years) and further studies are ongoing with a larger group of patients.
”The results from the published study are very promising and make up an additional development opportunity for the patented diagnostic method HMD-301", says Emanuel Björne, CEO of Hansa Medical AB
For further information, please contact:
Hansa Medical AB
Emanuel Björne, CEO
Mobile: 46 707 17 54 77